ARROWHEAD PHARMACEUTICALS, INC. (ARWR) /
The revenue of ARROWHEAD PHARMACEUTICALS, INC. over the past 10 years
Chart ARROWHEAD PHARMACEUTICALS, INC.: revenue, fiscal 2016–2025 Open the chart →ARROWHEAD PHARMACEUTICALS, INC. reported revenue of $829.45M in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $158.33K — up 523763% over 9 years. Year over year, revenue rose 5 times and fell 4 times. The largest one-year move was in fiscal 2025: up 23258%, from $3.55M to $829.45M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Sep 30, 2025 | $829.45M |
| 2024ended Sep 30, 2024 | $3.55M |
| 2023ended Sep 30, 2023 | $240.74M |
| 2022ended Sep 30, 2022 | $243.23M |
| 2021ended Sep 30, 2021 | $138.29M |
| 2020ended Sep 30, 2020 | $87.99M |
| 2019ended Sep 30, 2019 | $168.8M |
| 2018ended Sep 30, 2018 | $16.14M |
| 2017ended Sep 30, 2017 | $31.41M |
| 2016ended Sep 30, 2016 | $158.33K |
Fiscal years as ARROWHEAD PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ARROWHEAD PHARMACEUTICALS, INC.
- The profitability of ARROWHEAD PHARMACEUTICALS, INC.
- The cash flow of ARROWHEAD PHARMACEUTICALS, INC.
- The debt of ARROWHEAD PHARMACEUTICALS, INC.
- All of ARROWHEAD PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- VICRVICOR CORPORATION
- ADCAGREE REALTY CORPORATION
- OSKOshkosh Corporation
- WLKWestlake Corporation
- CTVACorteva, Inc.
Not investment advice. This page shows what ARROWHEAD PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.